1-11 of 11
Authors: John Suh
Journal Article
IMUN-08 DURABLE RESPONSE TO IPILIMUMAB-NIVOLUMAB (IPI-NIVO) IN ANTI-PD1 REFRACTORY MERKEL CELL CARCINOMA WITH LEPTOMENINGEAL DISEASE PROGRESSION Open Access
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i15, https://doi.org/10.1093/noajnl/vdae090.046
Published: 02 August 2024
Journal Article
OCTS-01 DOSE ESCALATION FOR PREOPERATIVE STEREOTACTIC RADIOSURGERY FOR PATIENTS WITH LARGE BRAIN METASTASES Open Access
Neuro-Oncology Advances, Volume 6, Issue Supplement_1, August 2024, Page i26, https://doi.org/10.1093/noajnl/vdae090.086
Published: 02 August 2024
Journal Article
THER-09. IMPACT OF KRAS MUTATION STATUS ON THE EFFICACY OF IMMUNOTHERAPY IN LUNG CANCER BRAIN METASTASES Open Access
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i12, https://doi.org/10.1093/noajnl/vdz014.052
Published: 12 August 2019
Journal Article
TRLS-05. EARLY RESULTS FROM A PROSPECTIVE PHASE I/II DOSE ESCALATION STUDY OF NEOADJUVANT RADIOSURGERY FOR BRAIN METASTASES Open Access
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i9, https://doi.org/10.1093/noajnl/vdz014.038
Published: 12 August 2019
Journal Article
RADI-25. REPEAT STEREOTACTIC RADIOSURGERY FOR RECURRENT BRAIN METASTASES Open Access
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i26, https://doi.org/10.1093/noajnl/vdz014.117
Published: 12 August 2019
Journal Article
RADI-35. AN ANALYSIS OF RESPONSE ENDPOINTS FOR BRAIN METASTASIS PATIENTS TREATED WITH STEREOTACTIC RADIOSURGERY AND PD(L)-1 INHIBITORS Open Access
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i28–i29, https://doi.org/10.1093/noajnl/vdz014.127
Published: 12 August 2019
Journal Article
THER-14. INFLUENCE OF CLINICAL PARAMETERS ON THE EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER BRAIN METASTASES (NSCLCBM) Open Access
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i13, https://doi.org/10.1093/noajnl/vdz014.057
Published: 12 August 2019
Journal Article
THER-13. IMMUNOTHERAPY VERSUS STANDARD OF CARE IN MELANOMA BRAIN METASTASES WITH KNOWN BRAF STATUS Open Access
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i13, https://doi.org/10.1093/noajnl/vdz014.056
Published: 12 August 2019
Journal Article
THER-02. IMPACT OF SYSTEMIC THERAPY IN MELANOMA BRAIN METASTASIS Open Access
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i11, https://doi.org/10.1093/noajnl/vdz014.045
Published: 12 August 2019
Journal Article
THER-10. IMPACT OF BRAF MUTATIONAL STATUS ON THE EFFICACY OF IMMUNOTHERAPY FOR MELANOMA BRAIN METASTASES Open Access
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i12–i13, https://doi.org/10.1093/noajnl/vdz014.053
Published: 12 August 2019
Journal Article
THER-16. EFFICACY OF UPFRONT IMMUNE CHECKPOINT INHIBITORS IN LUNG CANCER BRAIN METASTASIS Open Access
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Page i14, https://doi.org/10.1093/noajnl/vdz014.059
Published: 12 August 2019
